1. Home
  2. BOLD vs GORV Comparison

BOLD vs GORV Comparison

Compare BOLD & GORV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • GORV
  • Stock Information
  • Founded
  • BOLD 2018
  • GORV 1976
  • Country
  • BOLD United States
  • GORV United States
  • Employees
  • BOLD N/A
  • GORV N/A
  • Industry
  • BOLD
  • GORV Retail-Auto Dealers and Gas Stations
  • Sector
  • BOLD
  • GORV Consumer Discretionary
  • Exchange
  • BOLD Nasdaq
  • GORV Nasdaq
  • Market Cap
  • BOLD 30.3M
  • GORV 31.8M
  • IPO Year
  • BOLD 2024
  • GORV 2015
  • Fundamental
  • Price
  • BOLD $1.13
  • GORV $0.28
  • Analyst Decision
  • BOLD Buy
  • GORV Hold
  • Analyst Count
  • BOLD 3
  • GORV 2
  • Target Price
  • BOLD $4.00
  • GORV $2.00
  • AVG Volume (30 Days)
  • BOLD 79.0K
  • GORV 24.0M
  • Earning Date
  • BOLD 05-09-2025
  • GORV 05-15-2025
  • Dividend Yield
  • BOLD N/A
  • GORV N/A
  • EPS Growth
  • BOLD N/A
  • GORV N/A
  • EPS
  • BOLD N/A
  • GORV N/A
  • Revenue
  • BOLD N/A
  • GORV $767,257,000.00
  • Revenue This Year
  • BOLD N/A
  • GORV $15.65
  • Revenue Next Year
  • BOLD N/A
  • GORV $20.54
  • P/E Ratio
  • BOLD N/A
  • GORV N/A
  • Revenue Growth
  • BOLD N/A
  • GORV N/A
  • 52 Week Low
  • BOLD $1.06
  • GORV $0.13
  • 52 Week High
  • BOLD $10.13
  • GORV $3.77
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • GORV 56.61
  • Support Level
  • BOLD N/A
  • GORV $0.17
  • Resistance Level
  • BOLD N/A
  • GORV $0.38
  • Average True Range (ATR)
  • BOLD 0.00
  • GORV 0.08
  • MACD
  • BOLD 0.00
  • GORV 0.02
  • Stochastic Oscillator
  • BOLD 0.00
  • GORV 43.54

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About GORV Lazydays Holdings Inc.

Lazydays Holdings Inc operates recreational vehicle dealerships. It provides products and services for RV owners and outdoor enthusiasts. The company generates revenue by providing a full spectrum of RV products: New and pre-owned RV sales, RV parts and services, financing and insurance products, third-party protection plans, after-market parts and accessories, and RV camping facilities.

Share on Social Networks: